Viewing nowRasirect 1.0 mg (Rasagiline Mesylate)
Rasagiline Mesylate 1.56mg
Tablet · Prescription medication
Anguk New Pharm Co., Ltd.

MFDS item code 202003581 · Approved 2020.05.18
Treatment of idiopathic Parkinson’s disease
This medication is used as monotherapy or as an adjunct to dopamine agonists in the early stages of idiopathic Parkinson's disease. Additionally, it is used as an adjunctive therapy for patients experiencing motor fluctuations after taking levodopa during treatment, helping to alleviate symptoms. It is useful in improving the main symptoms of Parkinson's disease.
This drug is administered orally to adults once daily as monotherapy or adjunctive therapy. 1) Monotherapy or adjunctive therapy with a dopamine agonist: Administer 1mg orally once daily. 2) Adjunctive therapy with levodopa: The recommended starting dose in patients taking levodopa is 0.5mg once daily. If well tolerated but the clinical response is inadequate, the dose may be increased to 1mg once daily. This drug may be taken with or without food.
This medication should not be used by patients who are allergic to the active ingredient or any other ingredients. Patients currently taking or who have recently discontinued other MAO inhibitors or certain natural medicines should not use this medication. Patients taking certain medications such as pethidine, tramadol, or dextromethorphan should not use this medication together. This medication is not administered to patients with moderate to severe liver impairment. This medication can cause various side effects such as headaches, depression, hallucinations, dizziness, skin rashes, and myalgia. Particularly, patients with Parkinson's disease need to be cautious due to the possibility of developing dyskinesia, hypotension, and impulse control disorders. Serious side effects may arise when used with other antidepressants or sympathomimetics, hence concomitant use should be avoided. Additionally, this medication can cause drowsiness or sudden sleep onset, so caution is required when driving or operating machinery. Women who are pregnant or breastfeeding should use this medication with caution, and its safety in children has not been established. In case of overdose, serious symptoms such as hypertensive crisis and serotonin syndrome may occur, and immediate medical assistance should be sought. This medication should be stored in a cool place away from direct sunlight and kept out of reach of children.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to avoid exposure to air and moisture. It is advisable to store the medication in a cool place between 1 to 25 degrees Celsius.
White or almost white, flat round tablet with beveled edges
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRasagiline Mesylate 1.56mg
Tablet · Prescription medication
Anguk New Pharm Co., Ltd.

Rasagiline Mesylate 1.56mg
Tablet · Prescription medication
Hana Lundbeck Co., Ltd.

Rasagiline Mesylate 0.78mg
Tablet · Prescription medication
Korea Lundbeck Co., Ltd.

Rasagiline Mesylate 1.56mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Rasagiline Mesylate 0.78mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Rasagiline Mesylate 1.56mg
Tablet · Prescription medication
Korea Pharma Co., Ltd.

Rasagiline Mesylate 1.56mg
Tablet · Prescription medication
Myungin Pharmaceutical Co., Ltd.

Rasagiline Mesylate 0.78mg
Tablet · Prescription medication
Myungin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.